Use of rapid response team in hospital not linked with reduction in cardio arrests or deaths

December 02, 2008

Although there is an effort to implement rapid response teams in hospitals throughout the country, new research suggests that they do not result in a reduced rate of cardiopulmonary arrests or deaths, according to a study in the December 3 issue of JAMA.

Previous studies have found that patients often exhibit physiological deterioration hours before cardiopulmonary arrest. A rapid response team, also known as a medical emergency team, is a multidisciplinary team of intensive care unit (ICU) professionals charged with the evaluation, triage, and treatment of non-ICU patients with signs of clinical deterioration to reduce the rates of in-hospital cardiopulmonary arrests (codes) and the subsequent illness or deaths that follow. The Institute for Healthcare Improvement has recommended that hospitals implement rapid response teams as 1 of 6 strategies to reduce preventable in-hospital deaths. In response, hundreds of hospitals around the country have invested significant financial and personnel resources in implementing rapid response teams, despite limited published data supporting their effectiveness, according to background information in the article.

Paul S. Chan, M.D., M.Sc., of the Mid America Heart Institute and University of Missouri, Kansas City, and colleagues examined the association between a rapid response team intervention and long-term changes in hospital-wide cardiopulmonary arrest and mortality rates. The study included adult inpatients admitted between January 2004 and August 2007 at a 404-bed tertiary care academic hospital in Kansas City. Rapid response team education and program rollout occurred from September 1 to December 31, 2005. A total of 24,193 patient admissions were evaluated prior to the intervention (January 1, 2004 to August 31, 2005), and 24,978 admissions were evaluated after the intervention (January 1, 2006 to August 31, 2007).

During the 20-month period after intervention implementation, there were a total of 376 rapid response team activations. The most common reasons for rapid response team activation were altered neurological status, tachycardia (abnormally rapid heartbeat) exceeding 130 beats per minute, tachypnea (abnormally rapid breathing) exceeding 30 breaths per minute, and hypotension (abnormally low blood pressure) assessed as blood pressure lower than 90 mm Hg.

Hospital-wide code rates per 1,000 admissions were 11.2 before rapid response team intervention and 7.5 after rapid response team intervention. This was not associated with a reduction in the primary outcome measure of hospital-wide code rates, with decreases in non-ICU code rates accounting for the majority of this difference.

Case fatality rates after cardiopulmonary arrest were similar prior to and after the rapid response team intervention (77.9 percent vs. 76.1 percent). Hospital-wide mortality rates did not meaningfully change after the rapid response team intervention (3.22 preintervention vs. 3.09 postintervention per 100 admissions). Secondary analyses revealed few instances of rapid response team undertreatment or underuse that may have affected the mortality findings.

"We believe that this study provides important new insights regarding the effectiveness and limitations of rapid response team intervention and raises critical questions about whether recommendations to disseminate rapid response teams nationally are warranted without a demonstrable mortality benefit," the authors write.
-end-
(JAMA. 2008;300[21]:2506-2513. Available pre-embargo to the media at www.jamamedia.org)

Editor's Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

For More Information: Contact the JAMA/Archives Media Relations Department at 312-464-JAMA or email: mediarelations@jama-archives.org.

The JAMA Network Journals

Related Mortality Rates Articles from Brightsurf:

COVID-19 mortality rates higher among men than women
A new review article from Beth Israel Deaconess Medical Center (BIDMC) shows people who are biologically male are dying from COVID-19 at a higher rate than people who are biologically female.

Study links three key variables to higher rural mortality rates in US
Since the 1980s, the all-cause mortality rate for rural residents in the US has exceeded that of urban residents.

Anal cancer rates and mortality have risen dramatically among Americans
Rates of new anal cancer diagnoses and deaths related to human papillomavirus (HPV), the most common sexually transmitted infection, have increased dramatically over the last 15 years, according to researchers at The University of Texas Health Science Center at Houston (UTHealth).

Men with breast cancer face high mortality rates: Study
Men with breast cancer are more likely to die than their female counterparts, across all stages of disease, with the disparity persisting even when clinical characteristics, such as cancer types, treatment and access to care are considered, according to a study by Vanderbilt researchers published in JAMA Oncology.

Mortality rates of major league baseball players
Major league baseball (MLB) players had lower death rates overall and from many underlying causes of death compared with men in the general US population, differences that could be associated in part with the physical fitness required for their jobs.

New Labour's policies reduced geographical inequalities in infant mortality rates
Efforts by the Labour government to reduce inequalities between the most deprived areas of England and the rest of the country had a positive impact on infant mortality rates, suggests research by the Universities of Newcastle, Leeds, York, and Liverpool published online in the Journal of Epidemiology & Community Health.

Global colorectal cancer mortality rates predicted to rise
In the first effort to predict the future burden of colorectal cancer mortality globally, researchers note that colon and rectal cancer mortality rates are projected to decrease in most countries apart from some Latin American and Caribbean countries, but increases are predicted for several countries from Europe, North America and Oceania.

Mortality rates rising for Gens X and Y too
Declining life expectancies in the US include Gen X and Y Americans, in addition to the older Baby Boomers.

Drug resistant infections associated with higher in-hospital mortality rates in India
In one of the largest studies to measure the burden of antibiotic resistance in a low- or middle-income country, researchers at the Center for Disease Dynamics, Economics & Policy report that in-hospital mortality is significantly higher among patients infected with multi-drug resistant (MDR) or extensively drug resistant (XDR) pathogens including Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae and Acinetobacter baumannii.

How have mortality rates changed over time for infants, children?
Mortality rates for death from any cause declined in all age groups from 1999 to 2015 in a study that analyzed death certificate data for people younger than 25 in the United States, Canada and England/Wales. More than 1.1 million deaths occurred during the study period in the United States, where mortality rates for death from any cause were the highest.

Read More: Mortality Rates News and Mortality Rates Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.